Company intelligence / Profile preview

Cormis

Reading, Berkshire, United Kingdom

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Cormis is a specialist pharmaceutical and healthcare consultancy that provides capability development and commercial excellence services to the global life sciences industry. The company specializes in medical affairs, market access, and sales team effectiveness, offering bespoke training and strategic consulting to improve organizational performance. Founded in 2011, Cormis works with major pharmaceutical companies to enhance their engagement with healthcare professionals and optimize product launches. In 2020, the company was acquired by Ashfield (part of UDG Healthcare, now Inizio) to strengthen its strategic consulting portfolio and is now integrated into Inizio Advisory.

Industry: Consulting

Beyond the preview

Go deeper on Cormis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cormis.

Explore the full profile